MENU
ZYME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Zymeworks (ZYME) Ownership - Who owns Zymeworks?
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
897.52M
P/E Ratio
N/A
Total Cash
265.29M
Projected Growth
N/A
Total Debt
18.46M
Revenue
93.38M
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
3.81
Total Debt/Equity
N/A
Revenue/Share
1.23 USD as % of share price
Fundamentals
ZYME
Capitalization
898M
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
265M
Total Cash/Share
3.81
Total Debt
18.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.23%
Revenue
93.4M
ROE
N/A
Book Value
325M
P/B Ratio
2.76
Cash Flow
N/A
Earnings
-1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.03B
Current Ratio
4.71
Current Revenue Per Employee
94790.21
Dividends Per Share - Security
N/A
EBITDA
-110.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-23.22
Shares Held By Institutions
1.19B
Shares Outstanding - Current
69.7M
Total Liabilities
101M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.022
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company for cancer & autoimmune treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com